Brandtree

Who owns Zessly?

Zessly is owned by Sandoz (Switzerland, SIX: SDZ).[1]

This ownership is reported in official statements but has not yet been matched to a regulatory filing.

Evidence: Sandoz Group AG Integrated Annual Report 2025. Last checked .

Key facts

Current owner
Sandoz Group AG reported
Owner HQ
🇨🇭 Switzerland, Basel
Origin
🇨🇭 Switzerland
Founded
2018
Category
Healthcare & pharma › Drug makers › Generics & biosimilars
Parent ticker
SIX: SDZ
Last verified
· 1 sources

About Zessly

Zessly is Sandoz's biosimilar infliximab, an immunology medicine used in rheumatology, gastroenterology and dermatology. The biosimilars timeline in the 2025 annual report records its European launch in 2018, alongside the low-concentration Hyrimoz adalimumab and the pegfilgrastim Ziextenzo launched in Europe the same year.

Ownership timeline of Zessly

Owners of Zessly over 2018 to 2026 Sandoz start not recorded–present Sandoz (start not recorded) 2018201920202021202220232024202520262027
  1. Current owner Sandoz [1] reported

Where Zessly sits in Sandoz

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Where Zessly sits in Sandoz Tree of 14 brands under Sandoz. Sandoz Zessly Afqlir Binocrit Erelzi Hexal Hyrimoz and 8 more

Open the full Sandoz ownership tree →

See the full Sandoz brand portfolio (14) →

Other brands owned by Sandoz

Sandoz controls 14 brands on Brandtree, 14 of them in healthcare & pharma.

Also in healthcare & pharma

All Sandoz brands →

Other brands in generics & biosimilars, and who owns them

Sandoz has more brands in generics & biosimilars on Brandtree than any other owner: 14 of 18.

BrandOwnerOwner based in
Amneal Amneal 🇺🇸 United States
Nise Dr. Reddy's 🇮🇳 India
AvKARE Amneal 🇺🇸 United States
Omez Dr. Reddy's 🇮🇳 India

Every brand in generics & biosimilars and its owner →

About the owner: Sandoz

Sandoz is a publicly listed company headquartered in Basel, Switzerland, founded in 1886. Brandtree records 14 brands under its control, and it is listed as SIX: SDZ.

Sandoz is a Basel generics and biosimilars company that traces itself to the business Alfred Kern and Edouard Sandoz founded 140 years before 2026. Sandoz and Ciba-Geigy merged into Novartis in 1996; Sandoz was later re-established as Novartis's generics and biosimilars arm and was spun off on 4 October 2023, when its shares began trading on the SIX Swiss Exchange. Its 2025 net sales were USD 11,086 million, of which biosimilars were 30%.

Sandoz: full profile, brands and acquisition history →

🇨🇭 Zessly and other Swiss brands

Brandtree records a controlling owner for 128 brands that began in Switzerland. 35 of them (27%) are now controlled by a company headquartered in another country; Zessly is not one of them.

All Swiss brands and who owns them →

Frequently asked questions

Who is the parent company of Zessly?

The parent company of Zessly is Sandoz, a publicly listed company headquartered in Switzerland.

Is Zessly Swiss?

Yes. Zessly originated in Switzerland in 2018 and its owner, Sandoz, is also headquartered in Switzerland.

Is Zessly still owned by Sandoz?

Yes. As of 21 October 2026, Zessly is still owned by Sandoz. The ownership record was last checked against primary sources on that date.

Sources (1) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] Sandoz Group AG Integrated Annual Report 2025 — Sandoz Group AG, Annual report; retrieved 21 October 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.